Stuart Montgomery

31.5k total citations · 2 hit papers
335 papers, 23.9k citations indexed

About

Stuart Montgomery is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Stuart Montgomery has authored 335 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Pharmacology, 142 papers in Psychiatry and Mental health and 106 papers in Experimental and Cognitive Psychology. Recurrent topics in Stuart Montgomery's work include Treatment of Major Depression (216 papers), Bipolar Disorder and Treatment (79 papers) and Tryptophan and brain disorders (70 papers). Stuart Montgomery is often cited by papers focused on Treatment of Major Depression (216 papers), Bipolar Disorder and Treatment (79 papers) and Tryptophan and brain disorders (70 papers). Stuart Montgomery collaborates with scholars based in United Kingdom, Italy and Austria. Stuart Montgomery's co-authors include Marie Åsberg, Siegfried Kasper, Julien Mendlewicz, Joseph Zohar, Daniel Souery, Göran Sedvall, C. Perris, Daisy Schalling, Alessandro Serretti and David S. Baldwin and has published in prestigious journals such as The Lancet, Biological Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

Stuart Montgomery

324 papers receiving 22.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Depression Scale Designed to be Sensitive to Change

1979 11.1k citations Stuart Montgomery, Marie Åsberg profile →
A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE

1978 1.1k citations Marie Åsberg, Stuart Montgomery et al. Acta Psychiatrica Scandinavica profile →

Peers

Countries citing papers authored by Stuart Montgomery

Since Specialization

Citations

This map shows the geographic impact of Stuart Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Montgomery more than expected).

Fields of papers citing papers by Stuart Montgomery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Montgomery. The network helps show where Stuart Montgomery may publish in the future.

Co-authorship network of co-authors of Stuart Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Montgomery. A scholar is included among the top collaborators of Stuart Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Montgomery. Stuart Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mild motor signs and depression: more than just medication side effects? 2025 ·European Archives of Psychiatry and Clinical Neuroscience ·Antonina Luca, Maria Luca, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Raffaella Zanardi, Raffaele Ferri, Bartolo Lanuzza, Basilio Pecorino, Bernhard T. Baune, Giuseppe Fanelli, Chiara Fabbri, Alessandro Serretti	0
2	Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 2024 ·Journal of Affective Disorders ·Paolo Olgiati, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Raffaella Zanardi, Gernot Fugger, Raffaele Ferri, Mariangela Tripodi, Bernhard T. Baune, Chiara Fabbri, J. Mendlewicz, Alessandro Serretti	2
3	Age as a moderating factor of treatment resistance in depression 2023 ·European Psychiatry ·Alexander Kautzky, Lucie Bartova, Gernot Fugger, Markus Dold, Daniel Souery, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz, Chiara Fabbri, Alessandro Serretti, Dan Rujescu, Siegfried Kasper	4
4	Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression 2021 ·Current Medicinal Chemistry ·Marco Calabrò, Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, (unknown), Diana De Ronchi, Alessandro Serretti, Concetta Crisafulli	2
5	The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder 2021 ·The International Journal of Neuropsychopharmacology ·Lucie Bartova, Gernot Fugger, Markus Dold, Alexander Kautzky, (unknown), Dan Rujescu, Joseph Zohar, Daniel Souery, Julien Mendlewicz, Stuart Montgomery, Chiara Fabbri, Alessandro Serretti, Siegfried Kasper	2
6	Melancholic features in major depression – a European multicenter study 2021 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Markus Dold, Lucie Bartova, Gernot Fugger, Alexander Kautzky, (unknown), Chiara Fabbri, Stuart Montgomery, Joseph Zohar, Daniel Souery, Julien Mendlewicz, Alessandro Serretti, Siegfried Kasper	22
7	Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study 2018 ·Acta Psychiatrica Scandinavica ·Alexander Kautzky, Markus Dold, Lucie Bartova, Marie Spies, Georg S. Kranz, Daniel Souery, Stuart Montgomery, J. Mendlewicz, J. Zohar, Chiara Fabbri, Alessandro Serretti, Rupert Lanzenberger, Dimitris Dikeos, (unknown), Siegfried Kasper	99
8	Refining Prediction in Treatment-Resistant Depression 2017 ·The Journal of Clinical Psychiatry ·Alexander Kautzky, Markus Dold, Lucie Bartova, Marie Spies, Thomas Vanicek, Daniel Souery, Stuart Montgomery, Julien Mendlewicz, Joseph Zohar, Chiara Fabbri, Alessandro Serretti, Rupert Lanzenberger, Siegfried Kasper	58
9	Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants 2016 ·The Journal of Clinical Psychiatry ·Suresh Durgam, Willie Earley, Hua Guo, Dayong Li, György Németh, I. Laszlovszky, Maurizio Fava, Stuart Montgomery	92
10	PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway 2014 ·The Pharmacogenomics Journal ·Chiara Fabbri, Agnese Marsano, Diego Albani, (unknown), Raffaella Calati, Antonio Drago, Concetta Crisafulli, Marco Calabrò, Siegfried Kasper, Rupert Lanzenberger, Joseph Zohar, Alzbeta Juven‐Wetzler, Daniel Souery, Stuart Montgomery, Julien Mendlewicz, Alessandro Serretti	35
11	A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine 2014 ·Human Psychopharmacology Clinical and Experimental ·Stuart Montgomery, (unknown), (unknown), Lars Häggström	105
12	Consensus Statement on Depression in the Elderly 2013 ·Stuart Montgomery, Aartjan T.F. Beekman, Joel Sadavoy, Carl Salzman, Chris Thompson, (unknown), Cornelius Katona, Bruce G. Pollock, Charles F. Reynolds	0
13	Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes 2010 ·The World Journal of Biological Psychiatry ·Neslihan Aygün Kocabaş, Irina Antonijevic, (unknown), Carlos Forray, Siegfried Kasper, Y. Lecrubier, Sylvie Linotte, Isabelle Massat, Stuart Montgomery, (unknown), Pierre Oswald, Lenore Snyder, Daniel Souery, Joseph Zohar, Julien Mendlewicz	3
14	Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder 2007 ·The Journal of Clinical Psychiatry ·Daniel Souery, Pierre Oswald, Isabelle Massat, Ursula F. Bailer, (unknown), Koen Demyttenaere, Siegfried Kasper, Y. Lecrubier, Stuart Montgomery, Alessandro Serretti, Joseph Zohar, Julien Mendlewicz, (unknown)	371
15	WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder 2003 ·CNS Spectrums ·Christer Allgulander, Borwin Bandelow, Eric Hollander, Stuart Montgomery, David Nutt, Ahmed Okasha, Mark H. Pollack, Dan J. Stein, Richard P. Swinson	78
16	Partial Response and Nonresponse to Antidepressant Therapy 2002 ·The Journal of Clinical Psychiatry ·Robert M. A. Hirschfeld, Stuart Montgomery, Eugenio Aguglia, Mario Amore, Pedro L. Delgado, Markus Gastpar, Christopher J. Hawley, Siegfried Kasper, Michael Linden, J. Massana, Julien Mendlewicz, Hans‐Jürgen Möller, Charles B. Nemeroff, Jerónimo Saíz, Pedro Such, Riccardo Torta, (unknown)	148
17	Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder 2001 ·International Clinical Psychopharmacology ·Stuart Montgomery, Siegfried Kasper, Dan J. Stein, (unknown), Ole Lemming	136
18	Social phobia: diagnosis, severity and implications for treatment 1999 ·European Archives of Psychiatry and Clinical Neuroscience ·Stuart Montgomery	15
19	Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. 1989 ·PubMed ·A. Carlo Altamura, (unknown), (unknown), G Invernizzi, Mauro Percudani, Stuart Montgomery	47
20	Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline. 1978 ·British Journal of Clinical Pharmacology ·Stuart Montgomery, Börje Cronholm, Marie Åsberg, D. Montgomery	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact